Accessibility Menu
 
Viva Biotech logo

Viva Biotech

(OTC) VBIZF

Current Price$0.20
Market Cap$427.92M
Since IPO (2019)-64%
5 Year-76%
1 Year-7%
1 Month-41%

Viva Biotech Financials at a Glance

Market Cap

$427.92M

Revenue (TTM)

$3.70B

Net Income (TTM)

$385.43M

EPS (TTM)

$0.01

P/E Ratio

13.98

Dividend

$0.00

Beta (Volatility)

-6.36 (Low)

Price

$0.20

Volume

23

Open

$0.20

Previous Close

$0.20

Daily Range

$0.20 - $0.20

52-Week Range

$0.18 - $0.43

VBIZF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Viva Biotech

Industry

Life Sciences Tools and Services

Employees

2,169

CEO

Chen Mao

Headquarters

Shanghai, 201318, CN

VBIZF Financials

Key Financial Metrics (TTM)

Gross Margin

38%

Operating Margin

11%

Net Income Margin

13%

Return on Equity

6%

Return on Capital

3%

Return on Assets

3%

Earnings Yield

7.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$427.92M

Shares Outstanding

2.11B

Volume

23

Avg. Volume

84.891

Financials (TTM)

Gross Profit

$638.64M

Operating Income

$188.26M

EBITDA

$393.87M

Operating Cash Flow

$206.06M

Capital Expenditure

$118.03M

Free Cash Flow

$88.03M

Cash & ST Invst.

$1.13B

Total Debt

$1.33B

Viva Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$882.67M

-12.9%

Gross Profit

$310.88M

-6.5%

Gross Margin

35.22%

N/A

Market Cap

$427.92M

N/A

Market Cap/Employee

$207.43K

N/A

Employees

2,063

N/A

Net Income

$96.33M

+182.2%

EBITDA

$178.05M

+9.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$199.29M

+77.0%

Accounts Receivable

$630.06M

+54.7%

Inventory

$335.91M

+29.3%

Long Term Debt

$358.42M

-62.3%

Short Term Debt

$972.83M

+2.1%

Return on Assets

3.05%

N/A

Return on Invested Capital

3.34%

N/A

Free Cash Flow

$44.98M

+323.6%

Operating Cash Flow

$92.21M

+39.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTCHFPureTech Health plc
$1.65+0.00%
INRLFValneva SE
$2.58+0.00%
CLVSFCellaVision AB (publ)
$13.49+0.00%
BOIRFBoiron S.A.
$31.90+6.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
FFord Motor Company
$14.93+0.09%
NIONio
$5.20-0.07%
INTCIntel
$119.84+0.01%

Questions About VBIZF

What is the current price of Viva Biotech?

Viva Biotech is trading at $0.20 per share.

What is the 52-week range for Viva Biotech?

Over the past 52 weeks, Viva Biotech has traded between $0.19 and $0.43.

How much debt does Viva Biotech have?

As of the most recent reporting period, Viva Biotech reported total debt of $190.41M.

How much cash does Viva Biotech have on hand?

Viva Biotech reported $155.80M in cash and cash equivalents in its most recent financial results.

What is Viva Biotech’s dividend yield?

Viva Biotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.